[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

YU5800A - Univerzalno primenljiva krvna plazma - Google Patents

Univerzalno primenljiva krvna plazma

Info

Publication number
YU5800A
YU5800A YU5800A YU5800A YU5800A YU 5800 A YU5800 A YU 5800A YU 5800 A YU5800 A YU 5800A YU 5800 A YU5800 A YU 5800A YU 5800 A YU5800 A YU 5800A
Authority
YU
Yugoslavia
Prior art keywords
blood
blood plasma
universally applicable
plasma
applicable blood
Prior art date
Application number
YU5800A
Other languages
English (en)
Inventor
Wolfgang Marguerre
Tor-Einar Svae
Original Assignee
Octapharma Ag.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8227172&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=YU5800(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Octapharma Ag. filed Critical Octapharma Ag.
Publication of YU5800A publication Critical patent/YU5800A/sh
Publication of RS50016B publication Critical patent/RS50016B/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
  • Prostheses (AREA)

Abstract

Univerzalno primenljiva krvna plazma koja može da se dobije postupkom koji obuhvata stupnjeve mešanja krvi ili krvne plazme krvnih grupa A i B po izboru krvi ili krvne plazme krvne grupe AB bez primešavanja bitnih količina krvi ili krvne plazme koja potiče od krvne grupe O.[A universally applicable blood plasma obtainable by a process comprising the steps of mixing blood or blood plasma of blood groups A and B, optionally blood or blood plasma of blood group AB without admixing substantial amounts of blood or blood plasma derived from blood group O.
YUP-58/00A 1997-08-05 1998-08-04 Univerzalno primenjiva krvna plazma RS50016B (sr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97113466A EP0896824A1 (en) 1997-08-05 1997-08-05 A universally applicable blood plasma

Publications (2)

Publication Number Publication Date
YU5800A true YU5800A (sh) 2003-02-28
RS50016B RS50016B (sr) 2008-09-29

Family

ID=8227172

Country Status (25)

Country Link
US (1) US20110008459A1 (sh)
EP (2) EP0896824A1 (sh)
JP (1) JP2001513507A (sh)
CN (1) CN1272061A (sh)
AT (1) ATE225665T1 (sh)
AU (1) AU742427B2 (sh)
BG (1) BG64350B1 (sh)
BR (1) BR9811839A (sh)
CA (1) CA2299421C (sh)
CZ (1) CZ293726B6 (sh)
DE (1) DE69808620T3 (sh)
DK (1) DK0991416T4 (sh)
EA (1) EA003182B1 (sh)
ES (1) ES2185218T5 (sh)
HK (1) HK1026146A1 (sh)
HU (1) HU226548B1 (sh)
ID (1) ID24308A (sh)
IL (1) IL134308A (sh)
NO (1) NO326216B1 (sh)
NZ (1) NZ502661A (sh)
PL (1) PL193983B1 (sh)
PT (1) PT991416E (sh)
RS (1) RS50016B (sh)
TW (1) TW555563B (sh)
WO (1) WO1999007390A1 (sh)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6214221B1 (en) * 1999-02-22 2001-04-10 Henry B. Kopf Method and apparatus for purification of biological substances
CN1207004C (zh) * 2001-04-18 2005-06-22 马建川 通用型冻干血浆及其制备方法
JP2007514716A (ja) * 2003-12-19 2007-06-07 オクタファルマ アクチェン ゲゼルシャフト 非白色人種血漿の部分より製造される、万人に適用可能なウイルス不活化血漿
EP1958618A1 (de) 2007-02-15 2008-08-20 Octapharma AG Verfahren zur Gefriertrocknung mit optimierter Rekonstitution von Biopolymeren
BRPI1006722A2 (pt) 2009-04-09 2017-10-10 Entegrion Inc "método de preparação de hemoderivados desidratado, hemoderivados desidratados, bandagem ou auxílio cirúrgico, método para a preparação de plaquetas sanguíneas fixas desidratadas, plaquetas sanguíneas fixas desidratadas, método para o tratamento de um paciente que sofre de um distúrbio sanguíneo e plaquetas de sangue fixas secas por atomização tendo geometria com cavidades esféricas"
US8407912B2 (en) 2010-09-16 2013-04-02 Velico Medical, Inc. Spray dried human plasma
WO2011035062A2 (en) 2009-09-16 2011-03-24 Velico Medical, Inc. Spray dried human plasma
FR2963737B1 (fr) * 2010-08-16 2013-04-05 Etat Francais Ministere De La Defense Service De Sante Des Armees Procede de lyophilisation de plasma sanguin
US20140083628A1 (en) 2012-09-27 2014-03-27 Velico Medical, Inc. Spray drier assembly for automated spray drying
US8533971B2 (en) 2010-10-29 2013-09-17 Velico Medical, Inc. System and method for spray drying a liquid
US9561184B2 (en) 2014-09-19 2017-02-07 Velico Medical, Inc. Methods and systems for multi-stage drying of plasma
FR3026950A1 (fr) 2014-10-09 2016-04-15 Lab Francais Du Fractionnement Procede de preparation de plasma universel
FR3035799B1 (fr) 2015-05-06 2017-05-05 Elicityl Support pour la purification de liquides biologiques
FR3035794B1 (fr) 2015-05-06 2017-05-05 Elicityl Procede pour la purification du sang total ou d'un produit issu du sang
WO2019074886A1 (en) 2017-10-09 2019-04-18 Terumo Bct Biotechnologies, Llc LYOPHILIZATION CONTAINER AND METHOD OF USE
FR3083121B1 (fr) 2018-06-27 2021-10-22 Maco Pharma Sa Procede de greffage d un element fibreux pour l elimination d anticorps du sang ou d un composant sanguin
US11609042B2 (en) 2019-03-14 2023-03-21 Terumo Bct Biotechnologies, Llc Multi-part lyophilization container and method of use
DE102020212609B3 (de) * 2020-10-06 2022-04-07 Universität Greifswald Verfahren und Vorrichtung zur Herstellung von Universalplasma
US12083447B2 (en) 2022-09-15 2024-09-10 Velico Medical, Inc. Alignment of a disposable for a spray drying plasma system
US11841189B1 (en) 2022-09-15 2023-12-12 Velico Medical, Inc. Disposable for a spray drying system
US11975274B2 (en) 2022-09-15 2024-05-07 Velico Medical, Inc. Blood plasma product
US11998861B2 (en) 2022-09-15 2024-06-04 Velico Medical, Inc. Usability of a disposable for a spray drying plasma system

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4664913A (en) * 1982-05-24 1987-05-12 Xoma Corporation Method for treating plasma for transfusion
US4764369A (en) * 1983-07-14 1988-08-16 New York Blood Center Inc. Undenatured virus-free biologically active protein derivatives
US4551435A (en) * 1983-08-24 1985-11-05 Immunicon, Inc. Selective removal of immunospecifically recognizable substances from solution
JPH0723319B2 (ja) * 1986-05-14 1995-03-15 株式会社ミドリ十字 血液製剤から血液型抗体を除去する方法
DE4008852A1 (de) † 1990-03-20 1991-09-26 Octapharma Ag Verfahren zur herstellung von nicht-infektioesem blutplasma
US5217627A (en) * 1990-11-06 1993-06-08 Pall Corporation System and method for processing biological fluid
JP3575770B2 (ja) * 1992-03-31 2004-10-13 学校法人藤田学園 血漿由来製剤
AU667530B2 (en) * 1992-05-28 1996-03-28 New York Blood Center, Inc., The Removal of antibodies from blood-derived compositions while retaining coagulation factors

Also Published As

Publication number Publication date
WO1999007390A1 (en) 1999-02-18
DE69808620D1 (de) 2002-11-14
PL338794A1 (en) 2000-11-20
EP0896824A1 (en) 1999-02-17
IL134308A (en) 2004-09-27
TW555563B (en) 2003-10-01
NO20000578D0 (no) 2000-02-04
ATE225665T1 (de) 2002-10-15
HU226548B1 (en) 2009-03-30
EP0991416B1 (en) 2002-10-09
NZ502661A (en) 2001-03-30
ID24308A (id) 2000-07-13
PL193983B1 (pl) 2007-04-30
AU9256998A (en) 1999-03-01
HUP0004795A2 (hu) 2001-04-28
CA2299421A1 (en) 1999-02-18
CZ2000370A3 (cs) 2000-09-13
AU742427B2 (en) 2002-01-03
ES2185218T3 (es) 2003-04-16
BG64350B1 (bg) 2004-11-30
CN1272061A (zh) 2000-11-01
ES2185218T5 (es) 2008-04-16
DK0991416T3 (da) 2003-02-10
CZ293726B6 (cs) 2004-07-14
DK0991416T4 (da) 2008-02-25
EP0991416A1 (en) 2000-04-12
HUP0004795A3 (en) 2003-08-28
NO326216B1 (no) 2008-10-20
US20110008459A1 (en) 2011-01-13
EP0991416B2 (en) 2007-10-31
JP2001513507A (ja) 2001-09-04
RS50016B (sr) 2008-09-29
NO20000578L (no) 2000-03-27
PT991416E (pt) 2003-02-28
DE69808620T3 (de) 2008-05-21
EA003182B1 (ru) 2003-02-27
DE69808620T2 (de) 2003-06-26
EA200000196A1 (ru) 2000-10-30
BG104117A (en) 2000-12-29
IL134308A0 (en) 2001-04-30
HK1026146A1 (en) 2000-12-08
BR9811839A (pt) 2000-08-15
CA2299421C (en) 2009-11-10

Similar Documents

Publication Publication Date Title
YU5800A (sh) Univerzalno primenljiva krvna plazma
IL147803A0 (en) 28-epirapalogs
HK1112007A1 (en) Peptide acceptor ligation methods
AU6405198A (en) Plant for the treatment of products, which includes means for characterizing the products
DE69905170D1 (en) Thiazolopyrimidinderivate
AU7908298A (en) Endo-beta-1,4-glucanases from (saccharothrix)
AU3727397A (en) Elastomers, processes for their manufacture, and articles made from these elastomers
EP1105407A4 (en) AMINOSTEROLIC COMPOUNDS AND USES THEREOF
AU6926496A (en) New cyclic guanidines, process for preparing the same and medicaments
AU1817902A (en) Method for the preparation of 21-hydroxy-6,19-oxidoprogesterone (21oh-6op)
IL139604A0 (en) Novel peptides
AU3893493A (en) Micro-organisms, preparation method therefor and uses thereof
MX9603516A (es) Derivados de oxima y su uso como pesticidas.
AU8973398A (en) Organic compounds
MX9407877A (es) Sustrato de cultivo solido que incluye cebada.
EP0614971A3 (en) Novel cyclodextrin glucanotransferase, process for its manufacture and method for obtaining cyclodextrin using this enzyme.
DE69726602D1 (en) Hepatitis b inhibitoren
EP1048641A4 (en) APOPTOSIS-TIMER
EP0663207A3 (en) Bamboo salt manufacturing process.
IL138117A0 (en) 5-imino-13-deoxy anthracycline derivatives, their uses and processes for preparing them
DK1032580T3 (da) Fremgangsmåde til N-desmethylering af erythromyciner og derivater deraf
Pushpa Chaak
ZA965896B (en) Process for the preparation of alpha, omega-bromochloroalkanes.
ZA983781B (en) Process for the preparation of 1,1,1,3,3-pentachlorobutane.
WO1998059055A3 (de) Detoxifizierungsproteine